KDM4B overexpression promoted DNA damage in breast cancer cells which was significantly reduced upon pharmacological inhibition of KDM4B, by induction of apoptosis in triple negative breast cancers deficient in the tumor suppressor gene, PTEN (Wang W. et al., 2018; Xiang et al., 2019). Here, KDM4B is linked to breast carcinoma.